{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:43:10Z","timestamp":1765546990755,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-022-04646-x","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T03:38:47Z","timestamp":1665632327000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Live-attenuated measles, mumps, and rubella booster vaccine in children diagnosed with rheumatic disease: A single-center study"],"prefix":"10.1007","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-2480","authenticated-orcid":false,"given":"Figen","family":"\u00c7akmak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-0562","authenticated-orcid":false,"given":"\u00d6zlem","family":"Akg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9950-2489","authenticated-orcid":false,"given":"Fatma G\u00fcl","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-4575","authenticated-orcid":false,"given":"Ay\u015fe","family":"Tanatar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7490-7076","authenticated-orcid":false,"given":"G\u00fcl\u015fah Kavrul","family":"Kayaalp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonca","family":"Keskindemirci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1663-015X","authenticated-orcid":false,"given":"Vafa","family":"Guliyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rukiye Eker","family":"\u00d6mero\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine G\u00fclbin","family":"G\u00f6k\u00e7ay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-7387","authenticated-orcid":false,"given":"Nuray Aktay","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"4646_CR1","doi-asserted-by":"crossref","unstructured":"Karada\u011f \u015eG, S\u00f6nmez HE, Tanatar A, \u00c7akmak F, \u00c7akan M,\u00a0Ayaz NA (2020)\u00a0Profile of new referrals to a single pediatric rheumatology center in Turkey 40(2):313\u2013321","DOI":"10.1007\/s00296-019-04421-6"},{"key":"4646_CR2","doi-asserted-by":"crossref","unstructured":"Minden K, Horneff G, Niewerth M, Seipelt E, Aringer M, Aries P, Foeldvari I, Haas JP, Klein A, Tatsis S, Tenbrock K (2019) Time of disease\u2010modifying antirheumatic drug start in juvenile idiopathic arthritis and the likelihood of a drug\u2010free remission in young adulthood 71(4):471\u2013481","DOI":"10.1002\/acr.23709"},{"issue":"12","key":"4646_CR3","first-page":"3263","volume":"37","author":"HE Baris","year":"2018","unstructured":"Baris HE, Anderson E, Sozeri B, Dedeoglu FJCR (2018) Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis 37(12):3263\u20133273","journal-title":"Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis"},{"key":"4646_CR4","doi-asserted-by":"crossref","unstructured":"Becker I, Horneff GJAc (2017) Research: Risk of serious infection in juvenile idiopathic arthritis patients associated with tumor necrosis factor inhibitors and disease activity in the German Biologics in Pediatric Rheumatology Registry 69(4):552\u2013560","DOI":"10.1002\/acr.22961"},{"issue":"5","key":"4646_CR5","first-page":"1384","volume":"65","author":"T Beukelman","year":"2013","unstructured":"Beukelman T, Xie F, Baddley JW, Chen L, Delzell E, Grijalva CG, Mannion ML, Patkar NM, Saag KG, Winthrop KLJA et al (2013) Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis 65(5):1384\u20131389","journal-title":"Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis"},{"key":"4646_CR6","doi-asserted-by":"crossref","unstructured":"Aygun D, Sahin S, Adrovic A, Barut K, Cokugras H, Camc\u0131oglu Y, Kasapcopur OJCr (2019) The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study 38(4):1025\u20131030","DOI":"10.1007\/s10067-018-4367-9"},{"key":"4646_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-eular.6773","volume-title":"Thu0666 serious\/at least moderate infections in patients with juvenile idiopathic arthritis on synthetic and biologic drugs from the Pharmachild registry","author":"G Giancane","year":"2019","unstructured":"Giancane G, Swart JF, Tzaribachev N, Rubio N, Cuttica R, Rumba-Rozenfelde I, Suwairi WMS, Lazar C, Uziel Y, Telcharova A (2019) Thu0666 serious\/at least moderate infections in patients with juvenile idiopathic arthritis on synthetic and biologic drugs from the Pharmachild registry. BMJ Publishing Group Ltd, In"},{"key":"4646_CR8","doi-asserted-by":"crossref","unstructured":"Ada GJNEJoM (2001) Vaccines and vaccination. 345(14):1042\u20131053","DOI":"10.1056\/NEJMra011223"},{"key":"4646_CR9","doi-asserted-by":"crossref","unstructured":"Heijstek M, De Bruin LO, Bijl M, Borrow R, Van Der Klis F, Kon\u00e9-Paut I, Fasth A, Minden K, Ravelli A, Abinun M (2011) EULAR recommendations for vaccination in paediatric patients with rheumatic diseases 70(10):1704\u20131712","DOI":"10.1136\/ard.2011.150193"},{"key":"4646_CR10","doi-asserted-by":"crossref","unstructured":"Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, Van Assen S, Bijl M, Breedveld FC, D'amelio R, Dougados M, Kapetanovic MCJAotrd (2020)\u00a02019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases 79(1):39\u201352","DOI":"10.1136\/annrheumdis-2019-215882"},{"key":"4646_CR11","doi-asserted-by":"crossref","unstructured":"Borte S, Liebert U, Borte M, Sack U (2009)\u00a0Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept 48(2):144\u2013148","DOI":"10.1093\/rheumatology\/ken436"},{"key":"4646_CR12","doi-asserted-by":"crossref","unstructured":"Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E, Armbrust W, Hoppenreijs EP, Uiterwaal CS, Kuis W, Wulffraat NM (2007)\u00a0Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis 66(10):1384\u20131387","DOI":"10.1136\/ard.2006.063586"},{"issue":"23","key":"4646_CR13","first-page":"2449","volume":"309","author":"MW Heijstek","year":"2013","unstructured":"Heijstek MW, Kamphuis S, Armbrust W, Swart J, Gorter S, de Vries LD, Smits GP, van Gageldonk PG, Berbers GA, Wulffraat NMJJ (2013) Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial 309(23):2449\u20132456","journal-title":"Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial"},{"key":"4646_CR14","unstructured":"Bankowski Z, Bruppacher R, Crusius I, Gallagher J, Kremer G, Venulet JJGCfIOoMS (1999) Reporting adverse drug reactions"},{"issue":"1","key":"4646_CR15","first-page":"164","volume":"38","author":"M Bizjak","year":"2019","unstructured":"Bizjak M, Blazina \u0160, Markelj G, Av\u010din T, Toplak NJC, Rheumatology E (2019) Vaccination coverage in children with rheumatic diseases 38(1):164\u2013170","journal-title":"Vaccination coverage in children with rheumatic diseases"},{"key":"4646_CR16","doi-asserted-by":"crossref","unstructured":"Uziel Y, Moshe V, Onozo B, Kulcs\u00e1r A, Tr\u00f3bert-Sipos D, Akikusa JD, Pileggi GS, Maritsi D, Kasapcopur O, Rodrigues M (2020) Live attenuated MMR\/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: multicenter, retrospective data collection 38(9):2198\u20132201","DOI":"10.1016\/j.vaccine.2020.01.037"},{"key":"4646_CR17","doi-asserted-by":"crossref","unstructured":"Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM (2012)\u00a0Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study 71(6):948\u2013954","DOI":"10.1136\/annrheumdis-2011-200637"},{"key":"4646_CR18","doi-asserted-by":"crossref","unstructured":"Swart J, Giancane G, Horneff G, Magnusson B, Hofer M, Alexeeva \u0415, Panaviene V, Bader-Meunier B, Anton J, Nielsen S, De Benedetti F (2018) Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries 20(1):1\u201311","DOI":"10.1186\/s13075-018-1780-z"},{"key":"4646_CR19","doi-asserted-by":"crossref","unstructured":"Miyamoto M, Ono E, Barbosa C, Terreri M, Hilario M, Salom\u00e3o R,\u00a0Moraes-Pinto MD (2011)\u00a0Vaccine antibodies and T-and B-cell interaction in juvenile systemic lupus erythematosus 20(7):736\u2013744","DOI":"10.1177\/0961203310397409"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-022-04646-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-022-04646-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T15:13:43Z","timestamp":1673622823000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-022-04646-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["4646"],"URL":"https:\/\/doi.org\/10.1007\/s00431-022-04646-x","relation":{},"ISSN":["1432-1076"],"issn-type":[{"type":"electronic","value":"1432-1076"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"23 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethics committee approval (number: 816470) was obtained from Istanbul University, Faculty of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Because of the retrospective nature of the study, obtaining written informed consent from the patients was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}